Breakthrough at Michigan Medicine: Experimental Drug DT-109 Reverses Severe Fatty Liver Disease by Repairing the Gut-Liver Axis
Executive Overview In a monumental development for hepatology and metabolic medicine, researchers at Michigan Medicine have successfully reversed severe fatty...